跳至主要内容
临床试验/NCT05128149
NCT05128149招募中不适用

Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?

University Children's Hospital, Zurich1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Phe values

研究概览

简要总结

Treatment of PKU implies for most patients that with strict adherence to dietary treatment they can achieve excellent neurocognitive outcome. Dietary treatment, though, is hard to comply to every day and with every single meal. Unsurprisingly, health-related quality of life (HrQol) is negatively affected if patients have to follow a dietary regime of this kind. Adherence to treatment in PKU is very variable. Factors of significant impact on adherence to treatment and well-being in chronic disease such as self-efficacy or parenting stress have not yet been widely investigated in PKU patients.

The ideal treatment prescription (and guideline) recommends as much as necessary and as little as possible, based on the best evidence available. Patients should neither be deprived of treatment options nor be exposed to overtreatment.

This study investigates adherence, metabolic control, HrQol in PKU patients treated by centres which follow different guidelines

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with PKU from age 10 years requiring dietary and / or pharmacological treatment according to locally applied guidelines
  • Parents of patients with PKU aged 10 to 18 years requiring dietary and / or pharmacological treatment according to locally applied guidelines
  • Ability and willingness to answer the questionnaires and follow the study procedures
  • Informed consent as documented by signature
  • Exclusion criteria for patients and parents :
  • Inability to follow the procedures of the study, e.g. due to language problems or severely reduced health status
  • Pregnant patients or patients who have disclosed to their physician that they are planning a pregnancy in the near future
  • Hyperphenylalaninaemia or mild forms of PKU or other inborn errors associated with elevated Phe but not requiring dietary and / or pharmacological treatment according to locally applied guidelines
  • No inform

排除标准

  • 未提供

结局指标

主要结局

Phe values

时间窗: report on measurements from past 24 months

biochemical marker for PKU

次要结局

  • Health-related quality of life(one hour)
  • Burden on family (patients from 10-18 years)(one hour)
  • Self-efficacy(one hour)

研究者

发起方
University Children's Hospital, Zurich
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验